Paladin Labs is part of Endo International plc — a highly focused generics and specialty branded pharmaceutical company.   Learn More
   |   Endo.com

A leader in specialty pharmaceutical innovation

Welcome to Paladin Labs
With headquarters in Montréal, Canada, Paladin Labs Inc. is a leading specialty pharmaceutical company focused on acquiring or licensing emerging pharmaceuticals for the Canadian market.

Their dedicated sales and marketing organization has propelled Paladin to become one of Canada’s pioneers in specialty pharmaceuticals.

Paladin is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.

Investor Information

Endo International plc - Ordina

ENDP (Common Stock) NASDAQ
Price $13.12
Change and Percent Change +0.23 (+1.78%)



An innovative specialty pharmaceutical company